We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$6.45B
Cap. Flow %
0.91%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.77%
2 Consumer Discretionary 1.94%
3 Technology 1.9%
4 Communication Services 1.42%
5 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUPN icon
10201
PUT
Supernus Pharmaceuticals
SUPN
$2.54B
$376K ﹤0.01%
+12,200
New +$374K
TECX
10202
Tectonic Therapeutic
TECX
$696M
$376K ﹤0.01%
3,526
+1,160
+49% +$138K
EWO icon
10203
iShares MSCI Austria ETF
EWO
$209M
$375K ﹤0.01%
15,642
-10,725
-41% -$259K
FCPT icon
10204
PUT
Four Corners Property Trust
FCPT
$2.77B
$375K ﹤0.01%
13,600
-9,100
-40% -$257K
GAIA icon
10205
CALL
Gaia
GAIA
$39.4M
$375K ﹤0.01%
34,100
+22,900
+204% +$260K
GCO icon
10206
Genesco
GCO
$370M
$375K ﹤0.01%
+5,888
New +$319K
ISCG icon
10207
iShares Morningstar Small-Cap Growth ETF
ISCG
$994M
$375K ﹤0.01%
7,244
-324,352
-98% -$16.4M
JBL icon
10208
Jabil
JBL
$31.6B
$375K ﹤0.01%
6,451
-1,179
-15% -$64.9K
USA icon
10209
Liberty All-Star Equity Fund
USA
$1.85B
$375K ﹤0.01%
41,514
+29,994
+260% +$252K
ZY
10210
DELISTED
Zymergen Inc. Common Stock
ZY
$375K ﹤0.01%
+9,372
New +$370K
VEDL
10211
PUT
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$375K ﹤0.01%
26,400
-4,200
-14% -$58.9K
ARDX icon
10212
CALL
Ardelyx
ARDX
$984M
$374K ﹤0.01%
+49,300
New +$365K
OGE icon
10213
CALL
OGE Energy
OGE
$9.45B
$374K ﹤0.01%
11,100
-13,200
-54% -$445K
VRAY
10214
PUT
DELISTED
ViewRay, Inc.
VRAY
$374K ﹤0.01%
56,700
+1,500
+3% +$8K
CFRX
10215
PUT
DELISTED
ContraFect Corporation
CFRX
$374K ﹤0.01%
1,063
-790
-43% -$259K
CGEN icon
10216
CALL
Compugen
CGEN
$246M
$373K ﹤0.01%
45,100
-40,500
-47% -$329K
CRH icon
10217
CRH
CRH
$63.8B
$373K ﹤0.01%
7,333
-5,462
-43% -$273K
NZAC icon
10218
State Street SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$198M
$373K ﹤0.01%
+11,736
New +$367K
RGP icon
10219
PUT
Resources Connection
RGP
$146M
$373K ﹤0.01%
26,000
-55,900
-68% -$807K
RXL icon
10220
CALL
ProShares Ultra Health Care
RXL
$92.6M
$373K ﹤0.01%
8,000
-200
-2% -$8.75K
CERE
10221
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$373K ﹤0.01%
14,562
-173,726
-92% -$2.49M
TUFN
10222
PUT
DELISTED
Tufin Software Technologies Ltd.
TUFN
$373K ﹤0.01%
40,900
-38,000
-48% -$356K
GFF icon
10223
CALL
Griffon
GFF
$4.48B
$372K ﹤0.01%
14,500
-9,500
-40% -$254K
GHM icon
10224
PUT
Graham Corp
GHM
$1.01B
$372K ﹤0.01%
27,000
+5,000
+23% +$71K
OPLN
10225
CALL
Openlane
OPLN
$4.28B
$372K ﹤0.01%
+21,200
New +$359K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.